Phenylketonuria (PKU) can claim at least three ‘firsts’: the first
metabolic disorder to have a successful treatment; the first to be
controlled by diet; and the first to be detected by newborn
screening. This review describes the current management and
outcome of PKU and summarizes developments of new
therapies.